Isomerase Therapeutics' Corporate Minority Round

Isomerase Therapeutics raised a round of funding on January 14, 2016. Investors include NeuroVive.

Isomerase Therapeutics is a drug discovery and development company based in Cambridge, UK, with particular expertise in the discovery and development of optimized microbial natural products. The compa…

Articles about Isomerase Therapeutics' Corporate Minority Round: